ONTRUZANT® (trastuzumab-dttb) for Injection, for Intravenous Use 21 mg/ml

Please read the Prescribing Information for ONTRUZANT, including the
information about heart problems, infusion reactions (lung problems),
and harm to an unborn baby, and discuss it with your doctor.


HOW MAY WE ASSIST YOU?

THE ORGANON ACCESS PROGRAM

CAN HELP ANSWER QUESTIONS LIKE:

  • Does my insurance cover ONTRUZANT?
  • What options may be available for co-pay assistance?
  • Am I eligible for referral to the Organon Patient Assistance Program for eligibility determination (provided through the Organon Patient Assistance Program Inc.)?

A REPRESENTATIVE MAY BE ABLE TO:

  • Research your insurance benefits
  • Obtain information about your out-of-pocket costs
  • Provide information on co-pay assistance options for eligible patients
  • Refer you to the Organon Patient Assistance Program for eligibility determination (provided through the Organon Patient Assistance Program Inc.)
  • Answer questions about filling out the enrollment form
To get started, select a category above or call 844-326-2986 Mon-Fri 8 AM to 8 PM ET to speak with a representative.
  • Sign up With the Electronic Enrollment Form With E-Signature



 WELCOME TO

Welcome to The Organon Access Program for ONTRUZANT® (trastuzumab-dttb)

ARE YOU A US HEALTH CARE PROFESSIONAL?

Please choose